Genetic Diseases
Conditions
Interventions
intravenous tranexamic acid
normal saline
tranexamic acid as antifibrinolytic drug
Sponsors
lubabatu
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: all fibroid size between 12 to 24weeks
Exclusion criteria
Exclusion criteria: coagulopathy, repeat myomectomy, reaction to the drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| level of blood loss | — |
Secondary
| Measure | Time frame |
|---|---|
| mean blood transfusion rate | — |
Countries
Nigeria
Contacts
Public Contactmuhammad salisu
senior leturer
Outcome results
None listed